Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 402

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-10-4_003

تاریخ نمایه سازی: 23 تیر 1398

Abstract:

Background: This study was done to detect multidrug resistant (MDR) and extremely drug resistant (XDR) of Pseudomonas aeruginosa among strains isolated from patients in Tehran, Iran, due to importance of these phenotypes in treatment of human infections. Methods: Eighty eightP. aeruginosa were isolated from patients in Tehran, Iran, and identified by routine methods and PCR for oprL gene. Their antimicrobial susceptibility to 16 antimicrobial agents from 7 antimicrobial categories (aminoglycosides, carbapenems, cephalosporins, fluoroquinolones, penicillins/ß-lactamase inhibitors, monobactams, polymyxins) were determined by disk diffusion method, according to recommendation of Clinical and Laboratory Standards Institute. Characterization of P. aeruginosa isolates as MDR and XDR was done according to standardized international terminology presented by European Centre for Disease Prevention and Control as well as the Centers for Disease Control and Prevention in 2011. MDR was defined as acquired non-susceptibility to at least one agent in ≥3 antimicrobial categories and XDR was defined as non-susceptibility to at least one agent in ≥6 antimicrobial categories. Results: The rates of susceptibility to antimicrobials were as follows: gentamicin 27.3%, tobramycin 54.5%, amikacin 56.8%, netilmicin 36.4%, imipenem 55.7%, meropenem 55.7%, doripenem 60.2%, ceftazidime 63.6%, cefepime 56.8%, ciprofloxacin 59.1%, levofloxacin 60.2%, ticarcillin-clavulanic acid 37.5%, piperacillin-tazobactam 63.6%, aztreonam 43.2%, colistin 90.9%, polymyxin 95.5%. Altogether, 48 (54.5%) and 29 (33%) isolates were characterized as MDR and XDR, respectively. Discussion:The high frequency of antibiotic resistance in clinical isolates of P. aeruginosa in Iran makes epidemiological surveillance of susceptibility of this bacterium more essential for the best selection of empirical antibiotics.

Authors

Horieh Saderi

Molecular Microbiology Research Center, Shahed University, Tehran, Iran

Parviz Owlia

Molecular Microbiology Research Center, Shahed University, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J ...
  • Strateva T, Yordanov D. Pseudomonas aeruginosa a phenomenon of bacteria ...
  • Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter ...
  • Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection ...
  • Morales E, Cots F, Sala M, Comas M, Belvis F, ...
  • Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions ...
  • Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections ...
  • Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, ...
  • De Vos D, Lim A Jr, Pirnay JP, Struelens M, ...
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement.CLSI ...
  • Lu CL, Liu CY, Huang YT, Liao CH, Teng LJ, ...
  • Kim J, Lee KH, Yoo S, Pai H. Clinical characteristics ...
  • Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B ...
  • Lister PD, Gardner VM, Sanders CC. Clavulanate induces expression of ...
  • Moazami-Goudarzi S, Eftekhar F. Assessment of Carbapenem Susceptibility and Multidrug-Resistance ...
  • Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, ...
  • Bayani M, Siadati S, Rajabnia R, Taher AA. Drug Resistance ...
  • Nikokar I, Tishayar A, Flakiyan Z, Alijani K, Rehana-Banisaeed S, ...
  • Salimi H., Yakhchali B, Owlia P, Lari AR. Molecular Epidemiology ...
  • De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca ...
  • Tacconelli E, Tumbarello M, Bertagnolio S, Citton R, Spanu T, ...
  • Croft AC, D Antoni AV, Terzulli SL. Update on the ...
  • نمایش کامل مراجع